Ken Fisher’s Fulgent Genetics FLGT Stock Holding History

Ken Fisher’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-481	Closed	-$12.9K	–	1031
2023 Q3	$12.9K	Buy	481 +18	+4%	+$614	﹤0.01%	1089
2023 Q2	$17.1K	Sell	463 -123	-21%	-$4.29K	﹤0.01%	1087
2023 Q1	$18.3K	Buy	+586	New	+$18.9K	﹤0.01%	1032

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ken Fisher's FLGT Position: Q4 2023 in Review

Ken Fisher sold out of Fulgent Genetics (FLGT) in Q4 2023, closing a stake of 481 shares — an estimated $12.9K sold.

Ken Fisher first reported a position in FLGT in Q1 2023 and held it in 3 quarters. The position peaked at $18.3K in Q1 2023. 196 funds tracked by Wall St. Rank hold FLGT as of Q4 2023.

Ken Fisher reported no remaining Fulgent Genetics position as of Q4 2023 after selling out during the quarter.
Ken Fisher sold 481 Fulgent Genetics shares in Q4 2023, an estimated $12.9K.
Ken Fisher first reported a position in Fulgent Genetics in Q1 2023 and held it in 3 quarters.
Ken Fisher's Fulgent Genetics position peaked at $18.3K in Q1 2023.
196 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2023.

Based on Fisher Asset Management's 13F filing for Q4 2023, filed 6 Feb 2024.